SUN PHARMACEUTICAL INDUSTRIES LTD. Société Sun Pharmaceutical Industries Ltd. Bombay S.E.
Actions
SUNPHARMA
INE044A01036
Produits pharmaceutiques
|
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
| 1 522 INR | +0,47% |
|
+3,82% | +20,83% |
Métier
- médicaments génériques et OTC (94%) : destinés au traitement des maladies cardiologiques, psychiatriques, neurologiques, gastroentérologiques, diabétiques et respiratoires ;
- autres (6%) : notamment ingrédients pharmaceutiques actifs.
A fin mars 2021, le groupe dispose de 44 sites de production dans le monde.
La répartition géographique du CA est la suivante : Inde (33%), Etats-Unis (31,3%), autres (35,7%).
Nombre d'employés: 41 000
Ventes par activité
| INR en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 384 264 | 100,0 % | 432 789 | 100,0 % | +12,63% |
Ventes par région
| INR en Millions | 2022 | Poids | 2023 | Poids | Delta |
|---|---|---|---|---|---|
India
32,7
%
| 134 439 | 35,0 % | 141 624 | 32,7 % | +5,34% |
United States
32,3
%
| 117 344 | 30,5 % | 139 704 | 32,3 % | +19,06% |
Emerging Markets
19,8
%
| 72 757 | 18,9 % | 85 633 | 19,8 % | +17,70% |
Rest of the World
15,2
%
| 59 726 | 15,5 % | 65 827 | 15,2 % | +10,22% |
Dirigeants
| Dirigeants | Titre | Age | Depuis |
|---|---|---|---|
Aalok Shanghvi
CEO | Chief Executive Officer | - | - |
| Chief Executive Officer | 68 | 01/01/82 | |
| Director of Finance/CFO | - | 19/06/17 | |
Anil Rao
CTO | Chief Tech/Sci/R&D Officer | - | 01/06/22 |
Anoop Deshpande
CMP | Compliance Officer | - | 01/04/21 |
Nimish Desai
IRC | Investor Relations Contact | - | - |
Suresh Kumar Rai
HRO | Human Resources Officer | - | 07/12 |
S. Damodharan
PRN | Corporate Officer/Principal | - | - |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
| Corporate Officer/Principal | 65 | - |
Administrateurs
| Administrateurs | Titre | Age | Depuis |
|---|---|---|---|
| Chief Executive Officer | 68 | 01/01/82 | |
Rama Bijapurkar
BRD | Director/Board Member | 67 | 21/05/21 |
Rolf K. Hoffmann
BRD | Director/Board Member | 64 | 15/06/23 |
Aalok Shanghvi
BRD | Director/Board Member | - | - |
| Director/Board Member | 67 | 01/01/94 | |
| Director/Board Member | 60 | 01/11/22 | |
| Director/Board Member | 71 | 25/05/18 | |
| Director/Board Member | 68 | 21/05/21 | |
Abhay Gandhi
PRN | Corporate Officer/Principal | 59 | 01/04/07 |
Classe d'actions
| Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
|---|---|---|---|---|---|
| Action A | 1 | 2 399 334 970 | 1 087 080 856 ( 45,31 %) | 0 | 45,31 % |
Participations
| Nom | Actions | % | Valorisation |
|---|---|---|---|
SCPHARMACEUTICALS INC. 6,01% | 2 167 679 | 6,01% | 8 475 625 $ |
Coordonnées société
Sun Pharmaceutical Industries Ltd.
CTS No. 201 B/1, Sun House Western Express Highway
400063, Mumbai
+91 22 4324 4324
http://www.sunpharma.com
Sociétés du groupe
| Nom | Catégorie et Secteur |
|---|---|
Sun Pharma (Netherlands) BV
 Sun Pharma (Netherlands) BV Drugstore ChainsRetail Trade Sun Pharma (Netherlands) BV engages in the sale and distribution of generic medicine. The company is headquartered in Hoofddorp, the Netherlands. |
Drugstore Chains
|
Sun Pharma Laboratories Ltd.
 Sun Pharma Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Sun Pharma Laboratories Ltd. operates as a pharmaceutical company. The company is headquartered in Mumbai, India. |
Pharmaceuticals: Major
|
Basics GmbH
 Basics GmbH Medical DistributorsDistribution Services Part of Sun Pharmaceutical Industries Ltd., Basics GmbH is a pharmaceutical company based in Leverkusen, DE. The CEO of the company is Hellen de Kloet. The German company distributes high-quality and medically recognized prescription drugs, covering a wide range of therapeutic indications with their generics. For more information, healthcare professionals can log in with their access data on the company's website. The company's contact information is available on their website for customer service and orders. |
Medical Distributors
|
Sun Pharma Distributors Ltd.
|
Secteur
Ventes par région
Révisions de BNA
| Varia. 1 janv. | Capi. | |
|---|---|---|
| +28,00% | 22,83 Md | |
| +20,25% | 15,56 Md | |
| +18,82% | 14,34 Md | |
| +55,83% | 12,96 Md | |
| -0,05% | 6,79 Md | |
| -12,70% | 6,41 Md | |
| -8,87% | 5,73 Md | |
| +14,65% | 5,69 Md | |
| +9,49% | 4,75 Md |
- Bourse
- Actions
- Action SUNPHARMA
- Action SUNPHARMA
- Société Sun Pharmaceutical Industries Ltd.
